Rat Integrin alpha V beta 5 (ITGAV&ITGB5) Heterodimer Protein, His Tag&Tag Free, Unconjugated, Human

Catalog Number: ABS-IT5-R52E3-100UG
Article Name: Rat Integrin alpha V beta 5 (ITGAV&ITGB5) Heterodimer Protein, His Tag&Tag Free, Unconjugated, Human
Biozol Catalog Number: ABS-IT5-R52E3-100UG
Supplier Catalog Number: IT5-R52E3-100ug
Alternative Catalog Number: ABS-IT5-R52E3-100UG
Manufacturer: AcroBiosystems
Host: Human
Category: Proteine/Peptide
Species Reactivity: Rat
Conjugation: Unconjugated
Integrin alpha V beta 5 (ITGAV & ITGB5) is expressed on a wide variety of cell types including keratinocytes, fibroblasts, adhesive monocytes, embryonic stem cells, and select endothelium and epithelium. ITGAV & ITGB5 binds ligands containing an RGD motif, notably vitronectin. Growth factors that increase PKC activity, such as VEGF or TGF alpha, promote ITGAV & ITGB5mediated angiogenesis while alpha V beta 3, which may be expressed in the same cell, responds to FGFbasic and TNF alpha. An inhibitor of both down regulates tumor angiogenesis. During lung inflammation, up regulation of ITGAV & ITGB5 on myofibroblasts or infiltrating lymphocytes may contribute to fibrosis by freeing TGF beta from latency. - Proteine/Peptide
Molecular Weight: 112.3 kDa | 81.7 kDa
Tag: C-10*His | Native
NCBI: 001385621
Buffer: 50 mM Tris, 150 mM NaCl, pH7.5
Purity: 90%
Form: Powder
Target: Integrin alpha V beta 5
Immobilized Human Vitronectin at 5 µg/mL (100 µL/well) can bind Rat ITGAV&ITGB5 Heterodimer, His Tag&Tag Free (Cat. No. IT5-R52E3) with a linear range of 0.02-0.156 µg/mL (QC tested).
Immobilized Biotinylated Human Vitronectin at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Rat ITGAV&ITGB5 Heterodimer, His Tag&Tag Free (Cat. No. IT5-R52E3) with a linear range of 0.078-0.625 µg/mL (Routinely tested).
Rat ITGAV&ITGB5 Heterodimer, His Tag&Tag Free on SDS-PAGE under non-reducing (NR) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.